Related Experiment Video
Updated: Oct 23, 2025
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Autoimmune complications of COVID-19
Niloufar Yazdanpanah1,2, Nima Rezaei1,2,3
1Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Insights
The study explores how COVID-19 can trigger autoimmune conditions, such as hemolytic anemia and thyroid disease, in patients. Understanding the link between viral infection and autoimmunity is key for effective treatment strategies.
Area of Science:
- Immunology
- Infectious Diseases
- Virology
Background:
- The COVID-19 pandemic continues globally, with growing evidence of long-term health complications.
- Autoimmune manifestations are increasingly recognized as a significant late-onset complication following SARS-CoV-2 infection.
Purpose of the Study:
- To review and highlight the association between COVID-19 and the induction of various autoimmune diseases.
- To emphasize the need for further research into the pathophysiology of COVID-19-induced autoimmunity for improved patient management.
Main Methods:
- Literature review of reported cases and studies on autoimmune phenomena post-COVID-19.
- Analysis of clinical manifestations and immunological markers associated with these conditions.
Main Results:
- COVID-19 has been linked to autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, and Guillain-Barre syndrome.
- The presence of autoantibodies is frequently observed in patients with these post-COVID-19 autoimmune complications.
Conclusions:
- COVID-19 has a notable potential to induce or exacerbate autoimmune conditions.
- Differentiating between direct viral effects and autoimmune responses in COVID-19 pathogenesis is crucial for developing targeted therapies.
Abstract:
Coronavirus disease 2019 (COVID-19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID-19 disease period, there is an accumulating body of evidence concerning the late-onset complications of COVID-19, of which autoimmune manifestations have attracted remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain-Barre syndrome, and the detection of autoantibodies are the cues to the discovery of the potential of COVID-19 in inducing autoimmunity. Clarification of the pathophysiology of COVID-19 injuries to the host, whether it is direct viral injury or autoimmunity, could help to develop appropriate treatment.
More Related Videos
Related Concept Videos
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Rheumatic Heart Disease I: Introduction
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:14Myocarditis III: Medical Management
01:21Myocarditis I: Introduction